Pharming PHAR Cash Flow Statement (2019-2026)

NASDAQ PHAR
$11.34 -0.12 (-1.05%)
As of: Sep 4, 2026 · 11:24 AM EDT
Reported Financials

Pharming Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Pharming reported cash from operations of -$7.71M and free cash flow of -$7.38M for the quarter ended Jun 2026. This cash flow statement covers 24 quarters of results from Dec 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
12.22M-17.81M15.19M5.40M21.59M9.50M37.90M-20.80M-15.69M3.15M-13.48M-20.28M-19.70M4.01M-15.70M-3.68M-1.27M31.60M8.93M26.15M
Share-based CompensationStock Comp.
-3.70M1.91M1.64M1.07M1.97M3.32M5.69M2.92M2.64M4.51M2.58M6.58M
Gains from Sales and DivestituresGains Divest
-3.73M0.04M
Gains from Investment SecuritiesGains Investment
-0.16M-25.00M
Asset Writedowns and ImpairmentWritedown
0.69M
Non-cash ItemsNon-Cash Items
-25.10M9.00M11.69M6.08M-21.75M7.83M-2.57M-8.16M9.73M17.09M10.18M15.13M
Cash from OperationsCash from Ops.
5.51M7.06M12.62M0.61M-32.41M3.53M-17.30M-20.87M9.74M-1.79M10.71M-7.71M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
-4.41M2.06M1.95M2.19M2.90M7.55M5.63M2.74M7.70M3.21M6.15M
Change in Working Capital
Change in ReceivablesChange Receivables
4.65M2.96M4.05M-1.46M-5.54M-7.36M-18.54M-4.96M2.92M-6.78M-1.77M-1.56M-3.35M1.32M
Change in InventoryChange Inventory
-0.80M-6.15M0.42M-15.02M-10.72M-0.40M-14.43M-3.12M-2.13M-0.50M-1.29M-7.26M
Change in Account PayablesChange Payables
-0.99M-5.19M-2.33M-1.65M3.24M8.15M-2.25M6.56M-2.77M9.99M-13.16M
Change in TaxesChange Taxes
3.42M-1.23M
Other Working Capital ChangesOther WC Changes
2.89M-4.96M2.40M-0.39M-11.01M-4.56M-16.96M-10.33M7.35M-10.07M-21.45M-17.70M
Investing Activities
Capital ExpendituresCapex
-2.02M-10.74M-0.34M-1.38M-0.99M-0.15M-1.44M-0.29M-0.37M-0.79M-0.75M-0.32M
Change in IntangiblesChange Intangibless
-0.34M-3.45M0.24M-0.60M0.02M0.20M-0.01M-0.01M
Acquisitions
-0.51M-2.53M5.87M7.74M-57.48M5.87M6.13M
Change in Acquisitions & DivestmentsChange Acquisitions
-87.35M146.36M147.84M114.50M52.28M0.01M18.12M
Cash from Investing ActivitiesCash from Investing
-7.39M-21.30M-0.30M-0.38M-67.25M-58.23M-129.39M37.06M4.35M-9.79M-0.04M-84.84M
Financing Activities
Other financing activitiesOther financing
0.02M-0.32M0.25M-0.02M-0.05M-0.22M-0.02M-0.28M0.71M
Cash from Financing ActivitiesCash from Financing
-2.84M-27.95M-1.92M-4.98M-5.26M5.24M-1.04M-30.77M-1.43M-34.41M1.04M-11.67M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
-8.12M-7.88M-5.87M-7.94M
Additional items
Exchange Rate EffectFX Effect
4.40M-1.82M-11.66M-7.38M-0.91M0.44M-0.01M-2.21M1.24M-0.60M
Change in Cash
-16.50M-4.72M-11.41M189.67M-182.39M10.40M-2.65M184.78M-104.92M-49.46M-147.73M-14.59M12.66M-4.59M11.70M-104.22M
Beginning Cash Balance
205.16M191.92M207.34M61.74M54.94M
Free Cash FlowFCF
7.53M0.05M12.96M1.99M-31.42M3.67M-15.87M-20.57M10.11M-1.00M11.46M-7.38M
Net Cash FlowNCF
-4.72M-0.01M10.40M-4.75M-104.92M-49.46M-147.73M-14.59M12.66M-46.00M11.70M-104.22M